136 related articles for article (PubMed ID: 9270961)
1. Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?
Garcia Rodríguez LA; Ruigómez A
Epidemiology; 1997 Sep; 8(5):571-4. PubMed ID: 9270961
[TBL] [Abstract][Full Text] [Related]
2. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.
García Rodríguez LA; Ruigómez A; Panés J
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1418-23. PubMed ID: 18054750
[TBL] [Abstract][Full Text] [Related]
3. Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study.
Wei L; Ratnayake L; Phillips G; McGuigan CC; Morant SV; Flynn RW; Mackenzie IS; MacDonald TM
Br J Clin Pharmacol; 2017 Jun; 83(6):1298-1308. PubMed ID: 28054368
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study.
Neal KR; Scott HM; Slack RC; Logan RF
BMJ; 1996 Feb; 312(7028):414-5. PubMed ID: 8601113
[No Abstract] [Full Text] [Related]
5. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA; Lagergren J; Lindblad M
Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
[TBL] [Abstract][Full Text] [Related]
6. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
7. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
8. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
[TBL] [Abstract][Full Text] [Related]
9. Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
Neal K; Logan R
Aliment Pharmacol Ther; 2001 Jul; 15(7):1085-6. PubMed ID: 11421886
[No Abstract] [Full Text] [Related]
10. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
Tamim H; Duranceau A; Chen LQ; Lelorier J
Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for falls with use of acid-suppressive drugs.
Cea-Soriano L; Johansson S; García Rodríguez LA
Epidemiology; 2013 Jul; 24(4):600-7. PubMed ID: 23676267
[TBL] [Abstract][Full Text] [Related]
12. Long-term proton pump inhibitor therapy and risk of hip fracture.
Yang YX; Lewis JD; Epstein S; Metz DC
JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
[TBL] [Abstract][Full Text] [Related]
13. [Adverse events associated with long-term use of proton pump inhibitors].
Reimer C; Bytzer P
Ugeskr Laeger; 2012 Sep; 174(39):2289-93. PubMed ID: 23006222
[TBL] [Abstract][Full Text] [Related]
14. Gastric acidity inhibitors and the risk of intestinal infections.
Canani RB; Terrin G
Curr Opin Gastroenterol; 2010 Jan; 26(1):31-5. PubMed ID: 19907324
[TBL] [Abstract][Full Text] [Related]
15. [Ulcer drugs: profile of side effects of proton-pump blockers in comparison to H2 blockers in the spontaneous reporting system].
Hartmann K; Ciorciaro C; Kuhn M
Schweiz Med Wochenschr; 1996 Dec; 126(49):2114-8. PubMed ID: 8999498
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors: bacterial pneumonia.
Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
[TBL] [Abstract][Full Text] [Related]
17. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
18. Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious Gastroenteritis.
Chen Y; Liu B; Glass K; Du W; Banks E; Kirk M
PLoS One; 2016; 11(12):e0168618. PubMed ID: 27997598
[TBL] [Abstract][Full Text] [Related]
19. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
20. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
Dial S; Delaney JA; Barkun AN; Suissa S
JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
